Rob Bristow, MD, PhD, FRCPC
Senior Scientist, Princess Margaret Cancer Center
Dr. Bristow is currently a Clinician-Scientist at Princess Margaret Cancer Centre where he is treats genitourinary cancers and Professor within the Departments of Radiation Oncology and Medical Biophysics at the University of Toronto. His primary research interests are in tumour hypoxia, genome instability and prostate cancer genomics in the context of personalized cancer medicine.
Dr. Bristow is the lead PI for the Canadian component of the ICGC whole genome prostate cancer sequencing project (CPC-GENE) and is Head, Campbell Family Research Institute-PMH Prostate Cancer Research Program. He also serves on the Scientific Advisory Board/Committee for Prostate Cancer Canada (co-Chair), the Prostate Cancer Foundation (USA), the Advisory Council for Research (ACOR) of Canadian Cancer Society Research Institute, the Movember Global Strategic Committee and Action Plan (GAP) and the Cancer Research Society. He is past Chair of the Radiation Biology and Cancer Biology Committees of both ASTRO and CARO.
Dr Bristow is Editor of the 5th Edition Basic Science of Oncology and has over 200 published papers and book chapters. Dr Bristow has won a number of awards including the Virginia Logan Lectureship (Thomas Jefferson University), the Picchione Scholar Award (Pathology-Dalhousie University), Vivian Sakyly Visiting Professor (Oncology-McGill University) and the John F Ferguson Prostate Cancer Hero Award (Prostate Cancer Canada). He has also won numerous teaching and mentorship awards including the best Postgraduate Teacher at the University of Toronto’s Faculty of Medicine in 2011. He is twice a Canadian Foundation for Innovation (CFI) awardee. He was made a Canadian Cancer Society Research Scientist in 2004 and an ESTRO Honorary Fellow in 2011.